Related references
Note: Only part of the references are listed.p53: 800 million years of evolution and 40 years of discovery
Arnold J. Levine
NATURE REVIEWS CANCER (2020)
p53 modifications: exquisite decorations of the powerful guardian
Yanqing Liu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Mutant p53 in cancer therapy-the barrier or the path
Xiang Zhou et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Why are there hotspot mutations in the TP53 gene in human cancers?
Evan H. Baugh et al.
CELL DEATH AND DIFFERENTIATION (2018)
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53
Neil T. Pfister et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding
Peng Liao et al.
MOLECULAR CELL (2017)
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53
Tengfei Chao et al.
NATURE COMMUNICATIONS (2016)
Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator
Xiang Zhou et al.
ELIFE (2016)
The p53 C Terminus Controls Site-Specific DNA Binding and Promotes Structural Changes within the Central DNA Binding Domain
Oleg Laptenko et al.
MOLECULAR CELL (2015)
The role of ubiquitin modification in the regulation of p53
Andreas K. Hock et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
A positive feedback loop between EBP2 and c-Myc regulates rDNA transcription, cell proliferation, and tumorigenesis
P. Liao et al.
CELL DEATH & DISEASE (2014)
Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor
Jerson L. Silva et al.
BIOSCIENCE REPORTS (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
Qi Zhang et al.
EMBO MOLECULAR MEDICINE (2012)
Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages
Yogesh Kulathu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding
N. D. Marchenko et al.
CELL DEATH AND DIFFERENTIATION (2010)
Ubiquitination and degradation of mutant p53
Natalia Lukashchuk et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity
LJ Feng et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The p53-Mdm2 module and the ubiquitin system
D Michael et al.
SEMINARS IN CANCER BIOLOGY (2003)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
A Ito et al.
EMBO JOURNAL (2001)
Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination
S Nakamura et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins
E Kobet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
